Huaqing Wang
Tianjin University of Traditional Chinese Medicine(CN)Nankai University(CN)Tianjin First Center Hospital(CN)Tianjin Medical University Cancer Institute and Hospital(CN)Tianjin Nankai Hospital(CN)First Teaching Hospital of Tianjin University of Traditional Chinese Medicine(CN)Tianjin Medical University(CN)Beijing University of Chemical Technology(CN)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Lung Cancer Treatments and Mutations, Viral-associated cancers and disorders, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis(2014)479 cited
- → Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study(2018)135 cited
- → Antitumor Activity of Folate Receptor-Targeted Liposomal Doxorubicin in a KB Oral Carcinoma Murine Xenograft Model(2003)115 cited
- → Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies(2016)87 cited
- → Association between sleep traits and primary liver cancer: A Mendelian randomization analysis(2023)39 cited
- → Biosimilar candidate IBI305 plus paclitaxel/carboplatin for the treatment of non-squamous non-small cell lung cancer